A multi-center, open, long-term follow-up study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD inj. for Moderate to Severe Chronic Atopic Dermatitis: 5-year Results from the K0104 Extension Study
Subject who enrolled K0104 Clinical Trial(parent study).
Subjects who understand and voluntarily sign an informed consent form
Subjects who are expected to be unable to perform at least one follow-up during this study (K0104-E)
Subjects who has received/administered clinical trial drugs or medical devices by participating in other clinical trials until the first visit of this trial (K0104-E) after the completion of K0104 clinical trial
Subjects who are judged to be unsuitable for other researchers to participate in the research